Joel Isaacson & Co., LLC - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 66 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
Joel Isaacson & Co., LLC ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$77,000
+13.2%
20,0000.0%0.01%
+9.1%
Q2 2018$68,000
-46.0%
20,000
-66.7%
0.01%
-50.0%
Q1 2018$126,000
-11.3%
60,000
-14.3%
0.02%
-12.0%
Q4 2017$142,000
-56.3%
70,000
-0.9%
0.02%
-57.6%
Q3 2017$325,000
+113.8%
70,6600.0%0.06%
+103.4%
Q2 2017$152,000
-40.2%
70,660
-12.4%
0.03%
-42.0%
Q1 2017$254,000
+21.0%
80,6600.0%0.05%
+19.0%
Q4 2016$210,000
-33.1%
80,6600.0%0.04%
-34.4%
Q3 2016$314,000
+44.7%
80,6600.0%0.06%
+39.1%
Q2 2016$217,000
-12.5%
80,6600.0%0.05%
-16.4%
Q1 2016$248,000
-8.8%
80,660
+14.2%
0.06%
-17.9%
Q4 2015$272,000
+25.9%
70,6600.0%0.07%
+15.5%
Q3 2015$216,000
-28.0%
70,6600.0%0.06%
-24.7%
Q2 2015$300,000
+9.9%
70,6600.0%0.08%
+11.6%
Q1 2015$273,000
-70.1%
70,660
-47.9%
0.07%
-71.8%
Q4 2014$913,000135,6600.24%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Perceptive Advisors 6,574,060$27,874,0001.68%
SENZAR ASSET MANAGEMENT, LLC 798,381$3,385,0000.58%
Cormorant Asset Management, LP 850,000$3,604,0000.48%
Palo Alto Investors LP 2,135,739$9,056,0000.40%
Opus Point Partners Management, LLC 99,959$424,0000.34%
Granahan Investment Management 1,582,237$6,709,0000.19%
Joel Isaacson & Co., LLC 70,660$300,0000.08%
MARINER INVESTMENT GROUP LLC 59,700$253,0000.06%
MYCIO WEALTH PARTNERS, LLC 75,000$318,0000.06%
Cornerstone Capital, Inc. 59,200$251,0000.06%
View complete list of ACELRX PHARMACEUTICALS INC shareholders